Meiogenix Forms Strategic Advisory Board of Global AgTech Leaders to Accelerate Crop Breeding Transformation
.png)
Industry Veterans from Monsanto, Corteva, Cornell and others guideadvancement of targeted recombination technology platform
RESEARCH TRIANGLE PARK, N.C. – December9, 2025 – Meiogenix, a biotechnology companyharnessing epigenetics and AI-powered precision breeding, has assembled aworld-class advisory board of scientific and agriculture industry leaders toaccelerate deployment of its targeted recombination platform – poised todeliver the next major leap in plant breeding innovation.
The advisory board unites over a centuryof expertise across genetics, plant breeding, and commercialization fromorganizations including Monsanto, Corteva, CoverCress, Aramis Biotech, CornellUniversity, and France’s CNRS. Their collective insight will help accelerate theMeiogenix mission to unlock the full potential of natural crop diversity andbring more resilient, high-performing varieties to market faster.
“Assembling this group is a definingmoment for Meiogenix,” said Ricardo Garcia de Alba, CEO of Meiogenix. “Theseare the leaders who shaped modern seed innovation. Their counsel ensures thatour science translates into a global breeding platform redefining what’spossible, delivering genetic diversity faster, more predictably, and usinguntapped genetic resources.”
A New Era of Targeted Recombinationfor Precision Breeding
Meiogenix enables seed companies andplant breeders to enhance performance traits such as disease resistance, stresstolerance, and adaptability through precision-guided recombination. Thecompany’s platform offers a transformative path for developing non-GMOvarieties adapted to climate and market needs in record time.
As Meiogenix expands, the advisory boardwill play a central role in expanding partnerships with leading global seedcompanies, broadening the application of Meiogenix technology across row crops,vegetables and specialty crops.
“Meiogenixrepresents the most significant advance in targeted recombination since it wasfirst described nearly a century ago,” said Neal Gutterson, Meiogenix chairmanof the board and advisory board leader. “By accessing previously unavailable naturalgenetic diversity, Meiogenix is reinventing how we breed for resilience,productivity, and sustainability.”
Meiogenix Advisory Board Members
Dr. Neal Gutterson – System Board member of CGIAR and Partner & CTO at RadicleGrowth, Former CTO at Corteva and DuPont Pioneer. He also serves as Chairman ofthe Board for Meiogenix.
Dr. Marc Albertsen – Former Director of Trait Discovery, Corteva Agriscience.
Marc André D’Aoust – Co-Founder and CSO, Aramis Biotech.
Dr. Marlin Edwards – Former Chief Technology Officer, Monsanto Seeds.
Dr. Alain Nicolas – CNRS Research Director and Group Leader, Department of “Dynamics ofGenetic Information,” Institut Curie.
Dr. Wojtek Pawlowski – Professor of Plant Genetics and Plant Breeding, Cornell University.
Jerry Steiner – Former CEO, CoverCress; former EVP, Sustainability & CorporateAffairs, Monsanto.
